We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$16.7M
Cap. Flow
-$84.9M
Cap. Flow %
-4.82%
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 27.26%
2 Technology 26.93%
3 Industrials 17.12%
4 Consumer Discretionary 9.62%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAV icon
151
Viavi Solutions
VIAV
$9.18B
$2.83M 0.16%
260,935
-2,736
-1% -$29.8K
RLGT icon
152
Radiant Logistics
RLGT
$390M
$2.82M 0.16%
429,199
-8,111
-2% -$45.3K
RYTM icon
153
Rhythm Pharmaceuticals
RYTM
$7.95B
$2.74M 0.16%
153,786
+584
+0.4% +$14.7K
THRY icon
154
Thryv Holdings
THRY
$95.5M
$2.72M 0.15%
117,829
-2,259
-2% -$50.6K
LASR icon
155
nLIGHT
LASR
$2.88B
$2.69M 0.15%
264,692
-5,256
-2% -$60.5K
PRMW
156
DELISTED
Primo Water Corporation
PRMW
$2.67M 0.15%
174,160
-2,203
-1% -$33.7K
TCBK icon
157
TriCo Bancshares
TCBK
$1.82B
$2.62M 0.15%
63,106
-1,260
-2% -$60.7K
LQDT icon
158
Liquidity Services
LQDT
$1.28B
$2.62M 0.15%
199,109
-3,989
-2% -$54.3K
OMCL icon
159
Omnicell
OMCL
$1.7B
$2.6M 0.15%
44,275
+15,914
+56% +$878K
VMC icon
160
Vulcan Materials
VMC
$37B
$2.56M 0.15%
14,933
-217
-1% -$38.5K
HZNP
161
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.5M 0.14%
22,933
-229
-1% -$25.3K
SMLR
162
DELISTED
Semler Scientific
SMLR
$2.5M 0.14%
93,202
-29,061
-24% -$814K
SKY icon
163
Champion Homes
SKY
$5.05B
$2.49M 0.14%
33,120
-527
-2% -$34K
BRKR icon
164
Bruker
BRKR
$8.58B
$2.44M 0.14%
30,964
-328
-1% -$23.7K
MLAB icon
165
Mesa Laboratories
MLAB
$569M
$2.44M 0.14%
13,968
-307
-2% -$55K
VVX icon
166
V2X
VVX
$2.6B
$2.38M 0.14%
59,984
+41,943
+232% +$1.79M
ASLE icon
167
AerSale
ASLE
$274M
$2.37M 0.13%
+137,346
New +$2.44M
ZUMZ icon
168
Zumiez
ZUMZ
$330M
$2.35M 0.13%
127,677
-1,861
-1% -$42.8K
CALY
169
Callaway Golf Company
CALY
$3.04B
$2.35M 0.13%
108,490
-1,064
-1% -$24.1K
LIND icon
170
Lindblad Expeditions
LIND
$2.16B
$2.34M 0.13%
245,155
-4,840
-2% -$48.7K
HUBG icon
171
HUB Group
HUBG
$2.9B
$2.34M 0.13%
55,666
-19,346
-26% -$844K
EHC icon
172
Encompass Health
EHC
$12.5B
$2.29M 0.13%
42,383
-691
-2% -$40.2K
BWXT icon
173
BWX Technologies
BWXT
$15.5B
$2.22M 0.13%
35,253
-352
-1% -$21.2K
CW icon
174
Curtiss-Wright
CW
$25.6B
$2.17M 0.12%
12,309
-4,299
-26% -$728K
QRHC icon
175
Quest Resource Holding
QRHC
$31.2M
$2.15M 0.12%
349,922
+94,609
+37% +$608K

Similar funds

Rice Hall James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.

  • Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
  • Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
  • Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
  • Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
  • Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
  • Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.